• Home
  • Dosing and Safety Implications for Oncologists When Administering Everolimus to Patients With Hormone Receptor-Positive Breast Cancer.

Dosing and Safety Implications for Oncologists When Administering Everolimus to Patients With Hormone Receptor-Positive Breast Cancer.

Author List
Rugo HS
Publication
Clinical breast cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1195490
Publication Year
2015
PubMed ID
26507507
Publication Title
Rugo HS. Dosing and Safety Implications for Oncologists When Administering Everolimus to Patients With Hormone Receptor-Positive Breast Cancer. Clin Breast Cancer. 2016 Feb; 16(1):18-22.